Cancer in COVID-19 Times – A Narrative Review of Guidelines and Recommendations

Author(s) :

Alecsandra Gorzo1, Daniel Sur 1,2

1Department of Medical Oncology, “Ion Chiricuță” Oncology Institute, Cluj-Napoca, Romania

2Department of Medical Oncology, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania

Corresponding author: Alecsandra Gorzo, Email:

Published: 113 Journal of Medical and Radiation Oncology 1 (2021) 119-129, , , - DOI: 10.53011/JMRO.2021.01.11

Open Access

Full text


March 22, 2021 0 Comments


Coronavirus disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first reported to produce atypical pneumonia in Wuhan, China, in December 2019.  This outbreak escalated very quickly due to the high transmission rate, and therefore, on March 11, 2020, it was declared a pandemic by the World Health Organization. COVID-19 caused a massive hospital overload worldwide and instigated urgent adjustments in resource allocation. Compared to the general population, cancer patients are considered to be at high risk of developing severe infection due to their immunocompromised status. The purpose of this review was to highlight the impact of the COVD-19 pandemic on cancer care, available guidelines, and recommendations.

Notify of
Inline Feedbacks
View all comments